Introduction
During the replication of human immunodeficiency virus 1 (HIV-1), the viral RNA genome is converted into double-stranded proviral DNA during reverse transcription. Initiation of reverse transcription is primed by a cellular tRNA, tRNA Lys, 3 , which is selectively incorporated into the virus during its assembly. Fig. 1A shows the components of HIV-1. The virus particle is surrounded by membrane derived from the cell plasma membrane (PM) during viral budding. Proteins comprising the viral structure include the glycosylated envelope proteins and mature structural proteins resulting from the proteolytic processing of the Gag precursor protein: matrix (MA), underlying the membrane; capsid (CA), comprising the wall of the core, within which are two strands of viral RNA genome; and nucleocapsid (NC), binding to the viral RNA.
Additionally, three virally-encoded enzymes used during the HIV-1 lifecycle are protease (PR), reverse transcriptase (RT), and integrase (IN). PR and IN (not shown in Fig. 1A ) form homodimers or homotetramers while RT is a heterodimer. They are created upon processing of the Gag-Pol precursor protein by viral PR.
The replication cycle of HIV-1 is shown in Fig. 1B (for review, see [1] ). Briefly, HIV-1 envelope proteins bind to PM receptors of the target cell, resulting in fusion of viral and cell membranes. Upon its release into the cytoplasm, the CA core disassembles, and within the resulting nucleoprotein complex, the viral RNA genome is copied into a double-stranded cDNA by RT. The tRNA primer, which is annealed to the genomic RNA primer binding site (PBS), initiates reverse transcription [2] , a complex process involving multiple strand-transfer reactions facilitated by the NC protein, a nucleic acid chaperone [3] . The resultant double-stranded viral DNA within the pre-integration complex is translocated into the nucleus of the infected cell where it integrates into the host cell's DNA and codes for viral mRNA and proteins. Envelope protein and regulatory proteins are coded for by spliced mRNAs, while both Gag and Gag-Pol are translated from full-length viral RNA, which is packaged into assembling virions where it serves as viral genomic RNA.
The Gag and Gag-Pol proteins assemble at the PM, and during or immediately after budding from the cell, the viral PR is activated and cleaves the precursor proteins into the mature products shown in Fig. 1A . A number of host cell factors are packaged during the viral assembly step, including the tRNA Lys primer. Transfer RNAs are known to participate in a channeled life cycle in mammalian cells, and are virtually never free [4] . For this reason, the primer tRNA cannot be selected from the microenvironment and must be present in the mature CA core prior to initiation of reverse transcription, which may initiate prior to capsid disassembly [5, 6] . [7] . However, in avian retroviruses, tRNA Trp is the primer for all members of the avian sarcoma and leukosis virus group examined to date [8, 9] , whereas tRNA Pro is the common primer for murine leukemia virus (MuLV) [10] . ''Selective packaging of tRNA" refers to the increase in the percentage of the low molecular weight RNA population representing primer tRNA in going from the cytoplasm to the virus. For example, in avian myeloblastosis virus (AMV), the relative concentration of tRNA Trp changes from 1.4% to 32% [9] . In HIV-1 produced from COS7 cells transfected with HIV-1 proviral DNA, both primer tRNA [12] . In MuLV, selective packaging of primer tRNA Pro is less dramatic, going from a relative cytoplasmic concentration of 5-6% to 12-24% of low molecular weight RNA [9] . The selective concentration of tRNA Lys is required for optimizing both annealing and infec- tivity of the HIV-1 population [13] , and an understanding of this process requires an understanding of how viral RNA, tRNA
Lys
, and viral and cellular proteins interact during HIV-1 assembly.
Gag/Gag-Pol assembly
Gag alone is capable of forming extracellular Gag viral-like particles (VLPs), but this assembly requires RNA for its formation, and in the absence of genomic RNA, cellular RNA can perform this function [14] [15] [16] [17] . It is generally assumed that Gag forms multimeric complexes at cell membranes (PM or endosomal [18] ), but a premembrane formation of smaller Gag complexes containing genomic RNA has not been excluded. Genomic RNA is packaged through interactions between NC protein sequences in Gag with specific stem/loop structures at the 5 0 end of the genomic RNA [19, 20] . A potential role for MA, another nucleic acid binding domain, has also been proposed [21, 22] . The in vivo interaction of Gag with Gag-Pol has also been well documented [23, 24] , and it is believed that Gag-Pol is carried into the assembling particle by interaction with CA and spacer peptide-1 (SP1) domains of Gag [25] . Cryoelectron microscopy has indicated that in immature virions, Gag is radially distributed with the N-terminal sequences within the MA domain associated with membrane, and the C-terminal sequences coding for SP1-NC-spacer peptide 2 (SP2)-p6 domains nearest the center of the virion [26, 27] . Images of immature virions have suggested that Gag molecules may be arranged in interacting hexagonal bundles, with a Gag molecule at each vertex of the hexagon [28] [29] [30] [31] , a model supported by work studying the in vitro assembly of Gag [32] . The hexagonal order, however, appears to be primarily at the level of CA and SP1, and the N-or C-terminal regions of Gag are largely disordered [28] [29] [30] [31] , supporting the conclusion that Gag/Gag interactions occur primarily at the CA/SP1 region.
tRNA
Lys incorporation into HIV-1
Selective tRNA Lys packaging into HIV-1 occurs independent of the genomic RNA [11] . Gag-Pol is required for packaging tRNA Lys into Gag VLPs or into HIV-1 [11] , and more specifically, the thumb (TH) structural domain in RT plays an important role in the interaction between Gag-Pol and tRNA Lys [33] . Although Gag-Pol appears to play a role in stable incorporation of tRNA Lys , it is believed that Gag is responsible for selecting tRNA Lys isoacceptors for incorporation into VLPs. This selection is not direct but is mediated through specific interactions with the tRNA Lys binding protein, human lysyl-tRNA synthetase (LysRS) [34] [35] [36] [37] . LysRS is responsible for binding and aminoacylating all three tRNA Lys isoacceptors that are found in HIV-1 particles [38] . Gag alone is sufficient for incorporation of LysRS into Gag VLPs [38] , but as mentioned earlier, Gag-Pol is required for tRNA Lys incorporation as well [11] . Moreover, the packaging of tRNA Lys isoacceptors requires interaction with LysRS [39] but not aminoacylation of the tRNA [40] . The interaction of Gag with LysRS is specific, i.e., of nine aminoacyl-tRNA synthetases (aaRSs) and three related proteins tested, only LysRS is packaged into HIV-1 [41] . The domains critical for the interaction have been mapped to include the so-called motif 1 domain of LysRS and the C-terminal domain of CA [34] . Deletions that extend into either of these domains abolish the interaction in vitro and, importantly, eliminate packaging of LysRS into Gag VLPs [34] . Interestingly, both of these primarily helical regions are responsible for homodimerization of their respective proteins. An equilibrium binding constant of 310 nM was measured for the Gag/LysRS interaction in vitro, and CA alone binds to LysRS with a similar affinity (400 nM) as full-length Gag [35, 36] . Mutant Gag and LysRS that do not homodimerize still interact, suggesting that dimerization of each protein per se is not required for the interaction, even though amino acids proximal to regions involved in forming the homodimer interfaces contribute to heterodimer formation. Gel chromatography studies further support the formation of a Gag/LysRS heterodimer in vitro. It is not known, however, if Gag interacts in vivo with the monomeric, dimeric, or tetrameric state of LysRS [42] .
Newly-synthesized LysRS is the source of viral LysRS, which likely interacts with Gag before entering its identified steady-state cellular compartments (high molecular weight multisynthetase complex (MSC), nuclei, mitochondria, cell membrane) [41, 43] . Importantly, siRNA knockdown of newly synthesized LysRS (80%) results in similarly reduced levels of tRNA Lys packaging, tRNA Lys, 3 priming by reverse transcriptase, and viral infectivity [43] . It has also been reported that mitochondrial LysRS (mLysRS) is a source of viral LysRS [37, 44] . In human cells, cytoplasmic LysRS (cLysRS) and mLysRS are encoded from the same gene by means of alternate splicing. The two LysRS species share 576 identical amino acids, but mLysRS has a different N-terminus of 49 amino acids that contains a putative mitochondrial targeting sequence [45] . In HIV-1 produced from U937 cells, antibodies directed to full-length LysRS detected full-length and truncated species, while antibodies specific for the unique N-termini of cLysRS and mLysRS were only able to detect mLysRS. These data support the conclusion that mLysRS is a source of viral LysRS [37] . However, the conclusion that mLysRS is the sole source of viral LysRS contradicts several reports in which expression of exogenous cLysRS in transfected HIV-1 producing cells results in cLysRS incorporation [13, 34, 40, 46] . This enhancement in LysRS packaging is associated with increases in tRNA Lys packaging, tRNA Lys,3 annealing, and viral infectivity [13] .
We suggest that the inability to detect cLysRS in virions using antibodies directed to the N-terminus may be associated with the lability of the N-terminus of cLysRS [38] . In vitro mapping studies also support the possibility that both forms of LysRS are possible sources for viral packaged LysRS, as the region of interaction with Gag is the motif 1 dimer interface present in both mitochondrial and cytoplasmic forms of the synthetase [35, 36] .
Formation of the tRNA Lys packaging complex
While tRNA Lys is targeted for incorporation into HIV-1 by a specific interaction of HIV-1 Gag with LysRS, RT sequences within GagPol must also be present, or LysRS will be packaged without tRNA Lys [33, 38] . Predicted relationships within the putative tRNA Lys packaging complex are schematically shown in Fig. 2 , along with the mature protein sequences coded for by the Gag and Gag-Pol precursors. In Fig. 2 , a Gag/Gag-Pol/viral RNA complex interacts with a tRNA Lys, 3 /LysRS complex, with Gag binding specifically to LysRS, and tRNA Lys,3 binding to RT domain in Gag-Pol. In the virus, tRNA Lys,3 is uncharged (i.e., has a free 3 0 hydroxyl group on the ribose of the terminal adenosine) [47] , and must be in this state in order to act as a primer for RT. It is not known if tRNA Lys, 3 is uncharged at the time of these interactions, or if the interaction of Gag with LysRS facilitates deacylation and release of tRNA Lys from the synthetase. In vitro studies have shown that the presence of Gag inhibits aminoacylation by human LysRS but does not promote deacylation of Lys-tRNA Lys (R. Kennedy, M. Hong, and K. Musier-Forsyth, unpublished data). Based on the following data, we predict that the Gag/Gag-Pol ratio in the tRNA Lys packaging complex is lower than the ratio present in the budding virion. When transfected 293T cells producing HIV-1 are pulsed for 10 min with 35 S-Cys/Met, 15% of newly-synthesized Gag and >95% of newly-synthesized Gag-Pol are found associated with membrane domains enriched in lipid rafts [48] , a membrane microdomain from which HIV-1 is proposed to bud [49, 50] . The Gag and Gag-Pol molecules at this membrane domain are presumably interacting since the movement of Gag-Pol to membrane requires association with Gag, which is driven by the interaction between homologous Gag sequences within Gag and Gag-Pol [23, 51] . Since the ratio of synthesis of Gag/Gag-Pol in cells has been estimated to be approximately 20:1 [52] , the ratio of newly-synthesized Gag:Gag-Pol at lipid raft domains would be 3:1-much lower than the Gag:Gag-Pol ratio found in immature virions. It was observed that during a 30-min chase period, more Gag molecules moved towards lipid raft-enriched membrane [48] , implying that the tRNA Lys,3 packaging/annealing complex may represent a very early assembly intermediate to which more Gag is later added. However, this assembly intermediate has not been directly detected.
In such an assembly intermediate, Gag-Pol may be present as a dimer, which is required for later Gag and Gag-Pol processing [53] . Gag and Gag-Pol would be present in a 3:1 ratio. LysRS may be present as a monomer since monomeric LysRS has been shown to interact with monomeric Gag in vitro [36] . However, as mentioned earlier the oligomeric state of LysRS upon interaction with Gag in vivo is not known. Gag-Pol may adopt a conformation to interact with Gag, reminiscent of the intermolecular interaction between Pol and Gag in human foamy viruses [54] . Expression of HIV-1 Pol and Gag from separate plasmids in 293T cells results in the incorporation of Pol into Gag VLPs, and Pol can replace Gag-Pol in facilitating the selective incorporation of tRNA Lys into the Gag VLPs [55] . Recent reports also indicate that RT sequences alone can be incorporated into Gag VLPs, with apparent interactions occurring between MA and p6 sequences in Gag and the TH domain in RT [56, 57] . The association of Gag-Pol with Gag is most likely driven by an interaction between homologous Gag sequences in both molecules, and the model in Fig. 2 shows the additional interactions that have been proposed to date. The model shows tRNA Lys, 3 bound to TH in RT, which is based both on in vitro studies on the interaction of purified HIV-1 RT with tRNA Lys,3 [58, 59] , and in vivo studies on the effect of C-terminal deletions in Gag-Pol upon tRNA Lys,3 incorporation into HIV-1 [33, 60] . The model also shows the 5 0 region of viral genomic RNA. HIV-1 genomic RNA is packaged into the virus through interactions between NC sequences in Gag and specific stem/loop structures at the 5 0 end of the genomic RNA [19, 20] . The PBS is located within 100 nucleotides upstream of these sequences. Additional interactions between LysRS and genomic RNA proximal to the PBS may also facilitate tRNA targeting and placement (C. Jones, J. Saadatmand, L. Kleiman, and K. Musier-Forsyth, unpublished data). During viral maturation, the first PR cleavage is between SP1 and NCp7 [61] . An interaction between Pol and Gag could insure that Pol is retained in the partially closed budding particle if proteolytic cleavage initiates during assembly. The fact that p6 is required for the interaction of Gag with Pol is of interest in this context since it has been reported that the deletion of p6 from Gag resulted in a lower concentration of Pol products in PRpositive HIV-1, but no change in Gag-Pol incorporation in PR-negative viruses [62] .
The model in Fig. 2 suggests that an interaction between LysRS and Pol sequences might facilitate formation of the complex. In support of this model, an interaction between LysRS and the connection domain (CD)/RNaseH domains in RT has been reported [57] . LysRS and mature RT do not interact in vitro (T. Stello, L. Kleiman, and K. Musier-Forsyth, unpublished data), and thus, this interaction may only occur in the context of Pol or may be indirect, and the function of this interaction is not yet clear. Since C-terminal deletions of Gag-Pol that include the RT CD do not inhibit tRNA Lys,3 packaging [60] , the LysRS/RT interaction is not involved in facilitating tRNA Lys,3 packaging. On the other hand, virions in which Gag-Pol is C-terminally deleted through the RT CD do not contain annealed tRNA Lys, 3 . This could mean that a Gag/LysRS/RT interaction may be involved in conformational changes facilitating movement of tRNA Lys,3 towards the PBS.
In summary, based on the current estimates of 2500 Gag molecules in immature HIV-1 particles [31, 63, 64] , we estimate that within the tRNA Lys packaging complex, an early assembly intermediate, there may be approximately 300 molecules of Gag, 100 molecules of Gag-Pol, 25 molecules of LysRS [65] , and 20-25 molecules of tRNA Lys [47] in addition to viral genomic RNA. Our model in Gag-Pol. The highly basic NC protein contacts the viral RNA packaging signal, and additional contacts between the viral RNA and LysRS may also occur. The RNA secondary structure proximal to the PBS is taken from [84] . Previous in vitro studies have shown HIV-1 NC to be a very effective nucleic acid chaperone protein that facilitates nucleic acid remodeling events throughout the reverse transcription process [66] . Although NC can efficiently catalyze tRNA Lys, 3 annealing onto the PBS in vitro [67] , in viruses lacking active PR, tRNA annealing to the PBS still occurs, suggesting that the precursor protein Gag may act as a NA chaperone and facilitate this process in vivo [68, 69] . Indeed, GagDp6, which lacks the C-terminal p6 domain, and other assembly-competent Gag variants have been demonstrated to facilitate tRNA annealing and genome dimerization in vitro [70, 71] . New studies also show that Gag's chaperone activity is stimulated upon interacting with inositol phosphates in the PM (C. in vivo or in vitro to viral RNA by Gag has a reduced ability to initiate reverse transcription [72] and results in a less stably annealed state relative to tRNA Lys,3 annealed by NC [69] . This reduced ability of Gag-annealed tRNA Lys,3 to function as a primer for reverse transcription can be rescued by a transient exposure of total viral RNA isolated from PR-negative virions to NC. Taken together, these data suggest that tRNA Lys,3 annealing may be a two-step process, involving an initial Gag-facilitated annealing at the site of viral assembly, followed by a re-annealing by NC after protein processing. Alternatively, NC may chaperone the refolding of viral RNA into an alternative structure to the one stabilized by Gag. Evidence for an RNA structural change that could govern RT initiation has been described [73] .
Future prospects
Understanding the mechanism by which the tRNA packaging complex is targeted to the 5 0 region of the genomic RNA, and probing the timing of tRNA annealing in the viral lifecycle are just two of the open questions currently under investigation. Gag interacts with viral genomic RNA and the PM, but Gag's interactions with other host cell factors such as LysRS, ABCE1, cyclophilin A, Tsg101, and ALIX are also critical to virus infectivity [38, [74] [75] [76] [77] . Interaction with so many cellular factors may be achieved by distinct pools of Gag, each interacting with separate essential factors and ultimately mixing during assembly at the PM. How newly synthesized LysRS is diverted from its normal function in translation to interact with HIV components is not known, but one of the cellular pools of Gag presumably recruits LysRS from its normal role in translation to aid virus replication. aaRSs have been shown to function in a wide array of cellular processes that are distinct from aminoacylation [78] . The expanded functions of synthetases and other components of the MSC have been shown to be regulated at the level of posttranslational modification. For example, in the case of human glutamyl-prolyl tRNA synthetase (EPRS), phosphorylation is required for its release from the MSC and for formation of the heterotetrameric c-interferon-activated inhibitor of translation (GAIT) complex [79] [80] [81] . Recently, specific phosphorylation of human LysRS has been shown to regulate Ap 4 A production in response to immunological challenge [82] 
